Page 845 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition

Index 823

Fish-based. omega-3 fatty acid-enhanced diet, Gastrointestinal lymphoma, 718–723, 719t Gefitinib (Iressa), 262
308–309 diagnosis and clinical staging, 720–721 Geldanamycin, 271
intermediate- or high-grade alimentary
Gemcitabine
FISS. see Feline injection-site sarcoma
VetBooks.ir FIV. see Feline immunodeficiency virus lymphoma and large granular for canine osteosarcoma, 543t
lymphoma, 721
clinical use of, 194
Fixative, for biopsy sample, 61–62
Fixed risk allele, cancer and, 4 low-grade alimentary lymphoma, for gross metastatic disease, 547
Flow cytometry, 74 720–721 nucleoside transporters used by, 184
FLT. see 3’-deoxy-3’-fluorothymidine history, clinical signs, and physical pharmacology of, 194
Flunixin meglumine, 293t–294t examination findings, 720 for urinary bladder tumors, 649t–650t
Fluoroscopic abdominal anatomy, of intermediate- or high-grade alimentary Gene amplification, 40f, 42
interventional oncology, 174 lymphoma, 720 Gene delivery, 251
Fluoroscopy, of interventional large granular lymphoma, 720 liposomes for, 251–253
oncology, 174 low-grade alimentary lymphoma, 720 methods, 252t
5-Fluorouracil (5-FU), 184 pathology and natural behavior, 718–720 nonviral, 251–253, 252f
clinical use of, 194 intermediate- or high-grade alimentary suicide gene delivery and, 255
pharmacology of, 194 lymphoma, 720 targeted, 253–254
FNA. see Fine-needle aspiration large granular lymphoma, 720 viral vectors for, 251, 252f
FNAC. see Fine-needle aspiration cytology low-grade alimentary lymphoma, Gene-directed enzyme prodrug therapy
FOCMA. see Feline oncornavirus-associated 718–720 (GDEPT), 255, 255f
cell membrane antigen treatment and prognosis, 721–723 Gene-directed immunotherapy, 256
Folate, 309 intermediate- or high-grade alimentary Gene expression, 10, 151–154
Folate receptor 4 (FR-4), 233 lymphoma, 721–722, 722t differentiation and, 62
Follicle-stimulating hormone large granular lymphoma, 722 genomic imprinting and, 10
(FSH), 597 low-grade alimentary lymphoma, 721 profiling, 151
Follicular B-cell lymphoma, 153 role of radiation therapy in cats with B-cell lymphoma and, 153–154
Follicular lymphoma, 700t gastrointestinal lymphoma, 723 proteins controlling, 42
Folliculin, 104 role of surgery in cats with Gene gun, 251–253, 252t
syndrome involving, 652 gastrointestinal lymphoma, Gene replacement, cancer cell rescue by, 254
Folliculin gene, 2 722–723 Gene silencing, 10
Food and Drug Administration (FDA) supportive care for cats with Gene therapy
drug development and, 345 gastrointestinal lymphoma, 723 approaches to, 256
role of, 345 Gastrointestinal manifestation, of cancer p53 and, 254
Forkhead box P3 (FoxP3), 233 cancer cachexia/anorexia as, 98–100 barriers to, 253
Fractionation, 210–211 gastrointestinal ulceration as, 98–100, 99b conditionally replicating viruses and, 256
stereotactic radiation therapy and, Gastrointestinal stromal tumor (GIST) definition of, 251
213–214 cell characteristics in, 139 history of, 251
Freezing, of biopsy sample, 61–62 fine-needle aspiration of, 140f safety considerations for, 257
FSH. see Follicle-stimulating hormone immunohistochemical markers/panels for, Gene therapy vector system, 252t
Functional thyroid carcinoma, 575 72t–73t Genes
Fused PET/CT, 120f stem cell factor receptor and, 146 methods for analyzing, 146–147
Fusion gene, detection of, 148 Gastrointestinal tract, cancer of, 432–491 quantifying, 151–154
Fusion protein, 260–261 esophageal tumors, 449 tumor development/progression and, 147
exocrine pancreatic cancer, 451 Genetic instability, 7
G gastric cancer, 452 Genetics
G 1 /G 2 phase, S phase and mitosis, 210 hepatobiliary tumors, 454–455, 454f–455f, cancer risk and, 11–12, 13f–14f
Gabapentin, 292t–294t 454t skin cancer and, 354
Gamete, 36 oral tumors, 432 Genistein, 309–310
Gastric cancer, 452 perianal tumors, 468 Genitourinary tract tumor, 287t
comparative aspects of, 454 salivary gland neoplasia, 448 Genoa Registry of Animal Tumors, 83t
diagnostic techniques for, 453, 453f Gastrointestinal tumor Genomic dysregulation, in cancer, 146–147
history and clinical signs of, 453 cell characteristics in, 136 Genomic guardian, 38
incidence and risk factors for, 452 pain caused by, 287t Genomic hypomethylation, 269
pathology and natural behavior, Gastrointestinal ulceration, tumors associated Genomic imprinting, 10
452–453 with, 99b Genomic instability, 7, 56
prognosis for, 454 Gastrostomy tube Germ cell tumors, 598
treatment, 453–454 diets for, 305 dysgerminomas as, 598
Gastrinoma, 584–585 placement of, 304–305 teratoma as, 598
gastroduodenal ulceration and, 100 GCP. see Good clinical practice types of, 598
Gastrinoma-related Zollinger-Ellison G-CSF. see Granulocyte colony-stimulating Germinal center-like DLBCL, 153
syndrome, 100 factor GFR. see Glomerular filtration rate
Gastroduodenal ulceration, causes of, 100 GDEPT. see Gene-directed enzyme prodrug Giant cell bone tumor, 140
Gastrointestinal endocrine tumors, 584–585 therapy Gilman, Alfred, 182